ATE274500T1 - Anivirale 2,4-pyrimidindion-derivate und ein verfahren zu ihrer herstellung - Google Patents
Anivirale 2,4-pyrimidindion-derivate und ein verfahren zu ihrer herstellungInfo
- Publication number
- ATE274500T1 ATE274500T1 AT00908087T AT00908087T ATE274500T1 AT E274500 T1 ATE274500 T1 AT E274500T1 AT 00908087 T AT00908087 T AT 00908087T AT 00908087 T AT00908087 T AT 00908087T AT E274500 T1 ATE274500 T1 AT E274500T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- carbamoyl
- alkoxycarbonyl
- amino
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/62—Barbituric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/66—Thiobarbituric acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19990007165 | 1999-03-04 | ||
| PCT/KR2000/000166 WO2000051990A1 (en) | 1999-03-04 | 2000-03-03 | Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE274500T1 true ATE274500T1 (de) | 2004-09-15 |
Family
ID=19575584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00908087T ATE274500T1 (de) | 1999-03-04 | 2000-03-03 | Anivirale 2,4-pyrimidindion-derivate und ein verfahren zu ihrer herstellung |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6713486B1 (de) |
| EP (1) | EP1159271B1 (de) |
| JP (1) | JP2002538144A (de) |
| AT (1) | ATE274500T1 (de) |
| AU (1) | AU2946300A (de) |
| DE (1) | DE60013260T2 (de) |
| WO (1) | WO2000051990A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20000065885A (ko) | 1999-04-10 | 2000-11-15 | 최승주 | 항바이러스성 피리미딘다이온 유도체 및 그 제조방법 |
| CN102219750B (zh) * | 2001-10-26 | 2013-05-29 | P.安杰莱蒂分子生物学研究所 | 关于hiv整合酶的n-取代的羟基嘧啶酮甲酰胺抑制剂 |
| AU2002334205B2 (en) | 2001-10-26 | 2007-07-05 | Istituto Di Ricerche Di Biologia Molecolara P. Angeletti Spa | Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| EP1553949B1 (de) * | 2002-08-13 | 2007-04-18 | Warner-Lambert Company LLC | Pyrimidin-2,4-dion-derivate als matrix-metalloproteinase-hemmer |
| KR101237312B1 (ko) | 2006-02-10 | 2013-03-04 | 삼진제약주식회사 | 피리미딘다이온 유도체를 포함하는 ｃ형 간염의 예방 및치료용 약학 조성물 |
| EP2044037A2 (de) * | 2006-07-24 | 2009-04-08 | Gilead Sciences, Inc. | Hemmer reverser hiv-transkriptase |
| AR067181A1 (es) * | 2007-06-29 | 2009-09-30 | Gilead Sciences Inc | Inhibidores de transcriptasa inversa de hiv, composicion farmaceutica, uso del compuesto para preparar un medicamento, agente de combinacion farmaceutica y metodo de inhibicion de la replicacion de un retrovirus |
| US8354421B2 (en) * | 2007-06-29 | 2013-01-15 | Korea Research Insitute Of Chemical Technology | HIV reverse transcriptase inhibitors |
| US8119800B2 (en) * | 2007-12-21 | 2012-02-21 | Korea Research Institute Of Chemical Technology | Processes for preparing HIV reverse transcriptase inhibitors |
| PL2399910T3 (pl) | 2009-02-13 | 2014-09-30 | Shionogi & Co | Pochodne triazyny jako antagoniści receptora p2x3 i/albo p2x2/3 i kompozycja farmaceutyczna zawierająca je |
| RU2565073C2 (ru) | 2010-08-10 | 2015-10-20 | Сионоги Энд Ко., Лтд. | Триазиновое производное и включающая его фармацевтическая композиция, обладающая анальгетической активностью |
| US9212130B2 (en) * | 2010-08-10 | 2015-12-15 | Shionogi & Co., Ltd. | Heterocyclic derivative and pharmaceutical composition comprising the same |
| JP6124351B2 (ja) | 2012-02-09 | 2017-05-10 | 塩野義製薬株式会社 | 複素環および炭素環誘導体 |
| TWI637949B (zh) | 2013-06-14 | 2018-10-11 | 塩野義製藥股份有限公司 | 胺基三衍生物及含有其等之醫藥組合物 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU205917B (en) * | 1989-09-29 | 1992-07-28 | Mitsubishi Chem Ind | Process for producing 6-substituted pyrimidine derivatives and antiviral pharmaceutical compositions containing them as active components |
| EP0449726B1 (de) * | 1990-03-29 | 1997-06-11 | Mitsubishi Chemical Corporation | Pyrimidin-Nukleosid-Derivate und antivirale Mittel, die diese Derivate als aktiven Bestandteil enthalten |
| JPH07165731A (ja) * | 1993-10-21 | 1995-06-27 | Ajinomoto Co Inc | シクロプロパン誘導体及びそれを含有する抗ウイルス剤 |
| KR0151811B1 (ko) * | 1993-12-21 | 1998-10-15 | 강박광 | 신규한 항바이러스성 2,4-피리미딘디온 유도체 및 그의 제조방법 |
| CN1092647C (zh) * | 1996-02-22 | 2002-10-16 | 三进制药株式会社 | 新抗病毒的取代嘧啶二酮同素碳环核苷衍生物及其制备方法与含有其为活性成分的组合物 |
| KR100219922B1 (ko) * | 1996-05-16 | 1999-09-01 | 이서봉 | 신규한 항바이러스성 6-아릴옥시 및 6-아릴카르보닐 2,4-피리미딘디온 유도체 및 그의 제조 방법 |
| KR20000065885A (ko) * | 1999-04-10 | 2000-11-15 | 최승주 | 항바이러스성 피리미딘다이온 유도체 및 그 제조방법 |
-
2000
- 2000-03-03 US US09/913,391 patent/US6713486B1/en not_active Expired - Fee Related
- 2000-03-03 JP JP2000602217A patent/JP2002538144A/ja active Pending
- 2000-03-03 DE DE60013260T patent/DE60013260T2/de not_active Expired - Lifetime
- 2000-03-03 EP EP00908087A patent/EP1159271B1/de not_active Expired - Lifetime
- 2000-03-03 WO PCT/KR2000/000166 patent/WO2000051990A1/en active IP Right Grant
- 2000-03-03 AT AT00908087T patent/ATE274500T1/de not_active IP Right Cessation
- 2000-03-03 AU AU29463/00A patent/AU2946300A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60013260T2 (de) | 2005-08-11 |
| EP1159271A4 (de) | 2002-06-05 |
| WO2000051990A1 (en) | 2000-09-08 |
| JP2002538144A (ja) | 2002-11-12 |
| EP1159271B1 (de) | 2004-08-25 |
| AU2946300A (en) | 2000-09-21 |
| DE60013260D1 (de) | 2004-09-30 |
| US6713486B1 (en) | 2004-03-30 |
| EP1159271A1 (de) | 2001-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE274500T1 (de) | Anivirale 2,4-pyrimidindion-derivate und ein verfahren zu ihrer herstellung | |
| HUP0201646A2 (hu) | Új alfa-aminosav vegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények | |
| EA200970171A1 (ru) | Производные n-(аминогетероарил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии | |
| NO20025154D0 (no) | Imidazopyrimidinderivater og triazolpyrimidinderivater | |
| RU2014101244A (ru) | Способ получения гетероциклических соединений, включая транс-7-оксо-6-(сульфоокси)-1, 6-диазабицикло[3,2,1]октан-2-карбоксамид и его соли | |
| ATE375331T1 (de) | Amidderivate als inhibitoren der glycogensynthasekinase-3-beta | |
| JP2002531564A5 (de) | ||
| WO2007135380A3 (en) | Antiparasitic compounds and compositions | |
| BG93979A (bg) | Производни на n-(4-пиперидинил)(дихидробензофуран или дихидро-2н-бензопиран)карбоксамид, фармацевтичен състав, който ги съдържа, метод за получаване на производните и приложението им | |
| DE602004029237D1 (de) | Verfahren zur radiofluoridierung von biologisch aktiven vektoren | |
| TW200720252A (en) | Cyclic amine derivative having substituted alkyl group | |
| NO20075936L (no) | Fuserte heterocykliske forbindelser | |
| CA2368413A1 (en) | Derivatives of pyrimido[6,1-a]isoquinolin-4-one | |
| JP2004520296A5 (de) | ||
| WO2007068417A3 (en) | Process for the preparation of amines | |
| NO20082077L (no) | Spirosykliske quinazolinderivater som PDE7-inhibitorer | |
| HUP0303514A2 (hu) | AlfavBéta6 integrin inhibitorok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| CA2212007A1 (en) | Pyridonecarboxylic acid derivatives substitued by a bicyclic amino group | |
| EP1857459A3 (de) | Pyrazolopyrimidinverbindung und Verfahren zu ihrer Herstellung | |
| EP2289887A3 (de) | Epoxidcarboxylsäureamide, Azide und Aminoalkohole sowie Verfahren zur Herstellung von Alpha-Ketoamiden damit | |
| EP0125803A3 (de) | Pharmazeutisch aktive Dihydropyridine | |
| ATE199549T1 (de) | Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung | |
| NO20002589L (no) | Bifenylamidinderivater | |
| GB0302220D0 (en) | Use | |
| EA200300049A1 (ru) | Соединения для лечения нарушенной фундальной релаксации |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |